Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses
Open Access
- 1 January 2022
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 55, e00632022
Abstract
Mass vaccination campaigns are essential to control the ongoing novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic. The Covishield vaccine consists of the replication-deficient simian adenovirus vector ChAdOx1, which contains the full-length structural spike protein of SARS-CoV-2. Occasionally, it can lead to cutaneous reactions that contribute to fear of vaccination, hesitancy, and incomplete vaccination schedules. We report a case of facial angioedema following the first dose of Covishield in a 63-year-old woman with no previous history of allergies or hypersensitivity to drugs or vaccines. No rebound of angioedema was recorded after the second homologous and third heterologous doses.Keywords
This publication has 8 references indexed in Scilit:
- SARS‐CoV‐2 vaccine‐related cutaneous manifestations: a systematic reviewInternational Journal of Dermatology, 2022
- Cutaneous adverse events related to COVID ‐19 vaccines: A cross‐sectional questionnaire‐based study of 867 patientsDermatologic Therapy, 2021
- Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 casesBritish Journal of Dermatology, 2021
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic ThrombocytopeniaNew England Journal of Medicine, 2021
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialThe Lancet, 2020
- Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infectionBMJ Case Reports, 2020
- Urticaria (angioedema) and COVID‐19 infectionJournal of the European Academy of Dermatology and Venereology, 2020
- Vaccine-associated hypersensitivityJournal of Allergy and Clinical Immunology, 2018